{rfName}
Cl

Indexed in

License and use

Citations

Altmetrics

Impact on the Sustainable Development Goals (SDGs)

Analysis of institutional authors

Fernandez-Fernandez, BeatrizAuthor
Share
Publications
>
Article

Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology

Publicated to:NEFROLOGIA 45 (): 1-26 - 2025-04-01 45(), DOI: 10.1016/j.nefro.2024.11.002

Authors: Montero, Nuria; Oliveras, Laia; Martinez-Castelao, Alberto; Gorriz, Jose Luis; Soler, Maria Jose; Fernandez-Fernandez, Beatriz; Quero, Maria; Garcia-Carro, Clara; Garcia-Sancho, Paula; Goicechea, Marian; Martinez, Juan Jose Gorgojo; Molina, Pablo; Puchades, Maria Jesus; Rodriguez-Espinosa, Diana; Sablon, Nery; Santamaria, Rafael; Navarro-Gonzalez, Juan Francisco

Affiliations

Complex Hosp Univ Moises Broggi, Serv Endocrinol & Nutr, Barcelona, Spain - Author
Hosp Clin Barcelona, Serv Nefrol, Barcelona, Spain - Author
Hosp Gen Univ Gregorio Maranon, Serv Nefrol, RICORS 2040 Kidney Dis, Madrid, Spain - Author
Hosp Univ Bellvitge, Serv Nefrol, Barcelona, Spain - Author
Hosp Univ Fdn Alcorcon, Serv Endocrinol & Nutr, Madrid, Spain - Author
Hosp Univ Gran Canaria Dr Negrin, Serv Nefrol, Las Palmas Gran Canaria, Spain - Author
Hosp Univ Nuestra Senora Candelaria, Serv Nefrol, Santa Cruz De Tenerife, Spain - Author
Hosp Univ Nuestra Senora Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain - Author
Hosp Univ Vall dHebron, Vall dHebron Inst Res, Serv Nefrol, Barcelona, Spain - Author
Inst Salud Carlos III, RICORS2040 Kidney Dis RD21 0005 0013, Madrid, Spain - Author
RICORS2040 Kidney Dis RD21 0005 0013, Valencia, Spain - Author
Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Dept Med, Serv Nefrol & Hipertens,Fac Med,RICORS2040, Madrid, Spain - Author
Univ Complutense Madrid, Hosp Univ Clin San Carlos, Serv Nefrol, Madrid, Spain - Author
Univ Cordoba, Hosp Univ Reina Sofia, Serv Nefrol, Inst Maimonides Invest Biomed Cordoba IMIB, Cordoba, Spain - Author
Univ Fernando Pessoa Canarias, Fac Ciencias Salud, Las Palmas Gran Canaria, Spain - Author
Univ La Laguna, Inst Tecnol Biomed, San Cristobal la Laguna, Spain - Author
Univ Valencia, Hosp Clin Univ Valencia, Serv Nefrol, Valencia, Spain - Author
Univ Valencia, Hosp Univ Dr Peset, Serv Nefrol, FISABIO, Valencia, Spain - Author
See more

Abstract

To address all the changes in the management of people with diabetes (DM) and chronic kidney disease (CKD), under the auspices of the Spanish Society of Nephrology (SEN), the Spanish Diabetic Nephropathy Study Group (GEENDIAB) decided to publish an updated Clinical Practice Guideline for detection and management of diabetic kidney disease (DKD). It is aimed at a wide audience of clinicians treating diabetes and CKD. The terminology of kidney disease in diabetic patients has evolved towards a more inclusive nomenclature that avoids underdiagnosis of this entity. Thus, the terms "diabetes and kidney disease" and "diabetic kidney disease" are those proposed in the latest KDIGO 2022 guidelines to designate the whole spectrum of patients who can benefit from a comprehensive therapeutic approach only differentiated according to eGFR range and albuminuria. Recommendations have been divided into five main areas of interest: Chapter 1: Screening and diagnosis of diabetic kidney disease, Chapter 2: Metabolic control in people with diabetes and CKD, Chapter 3: Blood pressure control in people with diabetic kidney disease, Chapter 4: Treatment targeting progression of CKD in people with diabetic kidney disease, and Chapter 5: Antiplatelet or anticoagulant therapy in people with diabetes and CKD. World Health Organization (WHO) recommendations for guideline development were followed to report this guideline. Systematic reviews were carried out, with outcome ratings and summaries of findings, and we reported the strength of recommendations following the "Grading of Recommendations Assessment, Development and Evaluation" GRADE evidence profiles. (c) 2024 Sociedad Espanola de Nefrolog & imath;a. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).

Keywords

Quality index

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-25:

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 23.75.
  • The number of mentions on the social network X (formerly Twitter): 42 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Continuing with the social impact of the work, it is important to emphasize that, due to its content, it can be assigned to the area of interest of ODS 3 - Ensure healthy lives and promote well-being for all at all ages, with a probability of 75% according to the mBERT algorithm developed by Aurora University.